During the corresponding time, Sequenom Inc saw a revenue deteriorated by -10.62 % year on year, sequentially revenue grew by 6.23 %. While revenue at the Sequenom Inc's corporate clients
Sequenom Inc's Comment on Sales, Marketing and Customers
We consider the ordering physicians and client laboratories to be our customers,
and we have no single customer who accounted for over 10% of our revenue. However,
hundreds of third-party payors have reimbursed us for one or more of our tests.
Sequenom Inc’s Comment on Sales, Marketing and Customers
We consider the ordering physicians and client laboratories to be our customers,
and we have no single customer who accounted for over 10% of our revenue. However,
hundreds of third-party payors have reimbursed us for one or more of our tests.
Sources:
Sequenom Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Sequenom Inc’s corporate clients.
For your research, we’ve provided 9 tables on Sequenom Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
